Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study
- 5 April 2023
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 62 (1) , 106809
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cefepime vs Other Antibacterial Agents for the Treatment of Enterobacter Species BacteremiaClinical Infectious Diseases, 2014
- The Use of Cefepime for Treating AmpC β-Lactamase–Producing EnterobacteriaceaeClinical Infectious Diseases, 2013
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Antibiothérapie par voie générale dans les infections respiratoires basses de l’adulte. Pneumonie aiguë communautaire. Exacerbations de bronchopneumopathie chronique obstructiveMedecine Et Maladies Infectieuses, 2011
- Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for SepsisAntimicrobial Agents and Chemotherapy, 2010
- Emergence of Antibiotic Resistance during Therapy for Infections Caused by Enterobacteriaceae Producing AmpC β-Lactamase: Implications for Antibiotic UseAntimicrobial Agents and Chemotherapy, 2008
- Resistance in gram-negative bacteria: EnterobacteriaceaeAmerican Journal of Infection Control, 2006
- Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacter sppAntimicrobial Agents and Chemotherapy, 2001
- Development of resistance byEnterobacter cloacae during therapy of pulmonary infections in intensive care patientsJournal of Molecular Medicine, 1994
- Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during TherapyAnnals of Internal Medicine, 1991